rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2009-12-21
|
pubmed:abstractText |
The need to implement robust biomarkers in clinical trials has never been greater, and such efforts can be easily compromised by reagent instability or simple human error during assay set-up. Many biotechnology and pharmaceutical companies are introducing efforts to conduct biomarker studies under more rigorous settings, and the use of plates or tubes pre-loaded with stimulation or staining reagents could be of value for studies that involve flow cytometry.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1552-4957
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
59-64
|
pubmed:meshHeading |
pubmed-meshheading:19777549-Biological Markers,
pubmed-meshheading:19777549-Blood Cell Count,
pubmed-meshheading:19777549-Dimethyl Sulfoxide,
pubmed-meshheading:19777549-Flow Cytometry,
pubmed-meshheading:19777549-Humans,
pubmed-meshheading:19777549-Immunoassay,
pubmed-meshheading:19777549-Ionomycin,
pubmed-meshheading:19777549-Lymphocyte Activation,
pubmed-meshheading:19777549-Lymphocytes,
pubmed-meshheading:19777549-Ribosomal Protein S6,
pubmed-meshheading:19777549-Tetradecanoylphorbol Acetate
|
pubmed:year |
2010
|
pubmed:articleTitle |
Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays.
|
pubmed:affiliation |
Department of Medical Sciences, Amgen Inc., Thousand Oaks, California, USA.
|
pubmed:publicationType |
Journal Article
|